Terms: = Endocrine gland cancer AND TOP2A, TOP2, TP2A AND Treatment
31 results:
1. top2a modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation.
Zhang K; Zheng X; Sun Y; Feng X; Wu X; Liu W; Gao C; Yan Y; Tian W; Wang Y
Cancer Biol Ther; 2024 Dec; 25(1):2325126. PubMed ID: 38445610
[TBL] [Abstract] [Full Text] [Related]
2. Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis.
Yin M; Wang Y; Ren X; Han M; Li S; Liang R; Wang G; Gang X
Front Endocrinol (Lausanne); 2023; 14():1250033. PubMed ID: 38053725
[TBL] [Abstract] [Full Text] [Related]
3. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract] [Full Text] [Related]
4. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (
Zhou Y; Li J; Yang X; Song Y; Li H
Bioengineered; 2021 Dec; 12(2):12003-12022. PubMed ID: 34787052
[TBL] [Abstract] [Full Text] [Related]
5. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.
Kisling SG; Natarajan G; Pothuraju R; Shah A; Batra SK; Kaur S
Cancer Metastasis Rev; 2021 Sep; 40(3):721-738. PubMed ID: 34591244
[TBL] [Abstract] [Full Text] [Related]
6. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network.
Qian X; Chen Z; Chen SS; Liu LM; Zhang AQ
J Immunol Res; 2020; 2020():7503605. PubMed ID: 32537471
[TBL] [Abstract] [Full Text] [Related]
7. A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma.
Lotfi Shahreza M; Ghadiri N; Green JR
Sci Rep; 2020 Jun; 10(1):8846. PubMed ID: 32483162
[TBL] [Abstract] [Full Text] [Related]
8. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
[TBL] [Abstract] [Full Text] [Related]
9. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract] [Full Text] [Related]
11. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract] [Full Text] [Related]
12. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.
Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR
Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620
[TBL] [Abstract] [Full Text] [Related]
13. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
[TBL] [Abstract] [Full Text] [Related]
14. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract] [Full Text] [Related]
15. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
Atkin ND; Raimer HM; Wang YH
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
[TBL] [Abstract] [Full Text] [Related]
16. Identification of potential core genes and miRNAs in testicular seminoma via bioinformatics analysis.
Wang K; Chen Y; Zhao Z; Feng M; Zhang S
Mol Med Rep; 2019 Nov; 20(5):4013-4022. PubMed ID: 31545448
[TBL] [Abstract] [Full Text] [Related]
17. top2a as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
Ghisoni E; Maggiorotto F; Borella F; Mittica G; Genta S; Giannone G; Katsaros D; Sciarrillo A; Ferrero A; Sarotto I; Erriquez J; Di Renzo MF; Aglietta M; Valabrega G
J Ovarian Res; 2019 Feb; 12(1):17. PubMed ID: 30760286
[TBL] [Abstract] [Full Text] [Related]
18. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
[TBL] [Abstract] [Full Text] [Related]
19. The growth inhibitory effect of gambogic acid on pancreatic cancer cells.
Youns M; ElKhoely A; Kamel R
Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):551-560. PubMed ID: 29546614
[TBL] [Abstract] [Full Text] [Related]
20. Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M
Endocr Relat Cancer; 2017 Jul; 24(7):319-327. PubMed ID: 28432084
[TBL] [Abstract] [Full Text] [Related]
[Next]
